Rapid Pathogen Identification Platform
Infectious Diseases (e.g., UTI, Bloodstream, Respiratory)
Development/ValidationActive
Key Facts
Indication
Infectious Diseases (e.g., UTI, Bloodstream, Respiratory)
Phase
Development/Validation
Status
Active
Company
About Nostics
Nostics is pioneering a novel diagnostic platform that combines Raman spectroscopy, nanotechnology, and a proprietary Large Spectral Foundation Model (AI) to identify pathogens in under 10 minutes at the point of care. Founded in Leiden, Netherlands, the company addresses the critical need for rapid, accurate infection diagnostics to combat antimicrobial resistance and improve patient outcomes. Its portable, cartridge-based system is designed for decentralized settings, requiring no lab infrastructure or specialized skills. Nostics is a private, likely pre-revenue company backed by investors and recognized for its innovative approach with several awards.
View full company profile